Kieseier BC - Search Results

1

Subgroup and sensitivity analyses of annualized relapse rate over 2 years in the ADVANCE trial of peginterferon beta-1a in patients with relapsing-remitting multiple sclerosis.

Newsome SD, Kieseier BC, Arnold DL, Shang S, Liu S, Hung S, Sabatella G. Newsome SD, et al. Among authors: kieseier bc. J Neurol. 2016 Sep;263(9):1778-87. doi: 10.1007/s00415-016-8182-4. Epub 2016 Jun 17. J Neurol. 2016. PMID: 27314959 Free PMC article. Clinical Trial.

2

Statins as immunomodulators: comparison with interferon-beta 1b in MS.

Neuhaus O, Strasser-Fuchs S, Fazekas F, Kieseier BC, Niederwieser G, Hartung HP, Archelos JJ. Neuhaus O, et al. Among authors: kieseier bc. Neurology. 2002 Oct 8;59(7):990-7. doi: 10.1212/wnl.59.7.990. Neurology. 2002. PMID: 12370451

3

New immunopathologic insights into multiple sclerosis.

Hemmer B, Kieseier B, Cepok S, Hartung HP. Hemmer B, et al. Curr Neurol Neurosci Rep. 2003 May;3(3):246-55. doi: 10.1007/s11910-003-0085-y. Curr Neurol Neurosci Rep. 2003. PMID: 12691630 Free PMC article. Review.

4

Current disease-modifying therapies in multiple sclerosis.

Kieseier BC, Hartung HP. Kieseier BC, et al. Semin Neurol. 2003 Jun;23(2):133-46. doi: 10.1055/s-2003-41138. Semin Neurol. 2003. PMID: 12894379 Review.

5

Different effects of simvastatin and interferon beta on the proteolytic activity of matrix metalloproteinases.

Kieseier BC, Archelos JJ, Hartung HP. Kieseier BC, et al. Arch Neurol. 2004 Jun;61(6):929-32. doi: 10.1001/archneur.61.6.929. Arch Neurol. 2004. PMID: 15210533

6

Immune response to immunotherapy: the role of neutralising antibodies to interferon beta in the treatment of multiple sclerosis.

Hemmer B, Stüve O, Kieseier B, Schellekens H, Hartung HP. Hemmer B, et al. Lancet Neurol. 2005 Jul;4(7):403-12. doi: 10.1016/S1474-4422(05)70117-4. Lancet Neurol. 2005. PMID: 15963443 Review.

7

Therapeutic role of mitoxantrone in multiple sclerosis.

Neuhaus O, Kieseier BC, Hartung HP. Neuhaus O, et al. Among authors: kieseier bc. Pharmacol Ther. 2006 Jan;109(1-2):198-209. doi: 10.1016/j.pharmthera.2005.07.002. Epub 2005 Aug 10. Pharmacol Ther. 2006. PMID: 16095713 Review.

8

Clinical stabilization and effective B-lymphocyte depletion in the cerebrospinal fluid and peripheral blood of a patient with fulminant relapsing-remitting multiple sclerosis.

Stüve O, Cepok S, Elias B, Saleh A, Hartung HP, Hemmer B, Kieseier BC. Stüve O, et al. Among authors: kieseier bc. Arch Neurol. 2005 Oct;62(10):1620-3. doi: 10.1001/archneur.62.10.1620. Arch Neurol. 2005. PMID: 16216948

9

Multiple sclerosis: advances, excitements, disenchantments.

Kieseier BC, Wiendl H. Kieseier BC, et al. Lancet Neurol. 2006 Jan;5(1):2-3. doi: 10.1016/S1474-4422(05)70256-8. Lancet Neurol. 2006. PMID: 16361006 Review. No abstract available.

10

Mitoxantrone in multiple sclerosis.

Neuhaus O, Kieseier BC, Hartung HP. Neuhaus O, et al. Among authors: kieseier bc. Adv Neurol. 2006;98:293-302. Adv Neurol. 2006. PMID: 16400840 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

387 results

Search Page